MEDFIELD, Mass., June 21, 2010 (GLOBE NEWSWIRE) -- Symbollon Pharmaceuticals, Inc. (OTCBB:SYMBA) ( www.symbollon.com ) has announced today it has signed a non-exclusive joint venture agreement with Internet Marketing Consortium (IMC) to promote Iogen™. The purpose of the joint venture is to utilize the proprietary internet and multi-media marketing strategies and networks to promote Iogen™ through website sales on www.buyiogen.com . IMC is part of Beryl Wolk's family-owned businesses comprising 27 autonomous companies, employing 1,250 employees, with major facilities in four states and 66 offices worldwide. The parties will share 50/50% in the profits of the joint venture. Iogen™ is the first dietary supplement formulated to promote breast health for women suffering from breast pain and breast tenderness, fibrocystic breast disease, benign breast lumps and cysts.
Symbollon Forms Joint Venture With Internet Marketing Consortium To Promote Iogen(TM)
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.